{"product_id":"complete-conference-management-san-diego-heart-failure-symposium-for-primary-care-and-internal-medicine-physicians-2025","title":"Complete Conference Management San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians 2025","description":"\u003cdiv class=\"prod-edition\"\u003e\r\n\u003ch3 class=\"product_title entry-title\"\u003eComplete Conference Management San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians 2025\u003c\/h3\u003e\r\n\u003cstrong\u003e+ Include: 31 videos + 26 pdfs, size: 9.51 GB\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Target Audience: cardiologists, internists, primary care physicians\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Information:\u003c\/strong\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eThe 25th Annual San Diego Heart Failure Winter Symposium – New Strategies for Detection, Prevention and Treatment of Heart Failure\u003cstrong\u003e. \u003c\/strong\u003eThis year’s meeting will provide a comprehensive overview of strategies for detecting, preventing and treating heart failure. The talks, panel discussions and case presentations will focus on best practices and recent guideline recommendations as interpreted through the eyes of a renowned faculty. Throughout the two days, the faculty will provide expert insight and personal experience as they discuss the full range of management options that are available for patients throughout the spectrum of heart failure, ranging from Stage A (asymptomatic patients with risk factors) all the way to Stage D heart failure (highly symptomatic end-stage patients). New approaches for diagnosing heart failure and identifying specific groups of patients that require special management considerations (such as amyloid, hypertrophic and genetic cardiomyopathies) will be highlighted, rationale for guideline directed medical therapies (GDMTs) will be reviewed and strategies for successful implementation will be presented.\u003c\/li\u003e\r\n \t\u003cli\u003eThe Symposium combines didactic talks, panel discussions, case presentations and patient perspectives to provide a full and balanced overview of relevant management issues. The four highly focused sessions that comprise this year’s Symposium will cover topics related to Populations and Patients at Risk (Session I), Amyloid Heart Disease, Infiltrative Heart Disease, Hypertrophic and Other Forms of Inherited Cardiomyopathy (Session II), Identifying and Treating Heart Failure (Session III), Cardiogenic Shock, Percutaneous Devices to Support Cardiac Function, Emerging Strategies for Preventing Sudden Cardiac Death and Advances in Catheter Based Treatment of Atrial Fibrillation and Valvular Disease (Session IV). During each session, the audience will have an opportunity to comment on the talks and question the faculty on their thoughts about the best approaches for patient management. Our goal, as always, is to provide cutting edge information in a format that will enhance adaption of the knowledge that is gained into clinical practice.\u003cstrong\u003e \u003c\/strong\u003e\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\r\n\r\nAt the conclusion of this activity, participants should be able to:\r\n\u003col\u003e\r\n \t\u003cli\u003eSummarize current and emerging treatments available for preventing and treating heart failure and provide information to help in the selection of the most effective choices in individual patients.\u003c\/li\u003e\r\n \t\u003cli\u003eReview strategies for implementing medical and device therapies that will lead to improved outcomes in heart failure patients.\u003c\/li\u003e\r\n \t\u003cli\u003eDefine how specific populations including minorities, women and the elderly respond to various approaches to treating risk factors and heart failure.\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\r\n\r\nThis course is designed for cardiologists, internists, primary care physicians, nurses, PA’s, PharmD’s and all other allied healthcare professionals with an interest in heart failure.\r\n\r\n \r\n\r\n\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003e01 Identifying Patients at Risk for Developing Heart Failure\u003c\/li\u003e\r\n \t\u003cli\u003e02 Using SGLT inhibitors to Prevent CV Disease and Heart Failure\u003c\/li\u003e\r\n \t\u003cli\u003e03 GLP-1 Agonists for Reducing Weight, Preventing CV Disease and Treating Heart Failure\u003c\/li\u003e\r\n \t\u003cli\u003e04 Identifying and Treating Patients with Dyslipidemia\u003c\/li\u003e\r\n \t\u003cli\u003e05 Use of Non-Steroidal MRAs To Prevent CV Disease, CKD and Heart Failure\u003c\/li\u003e\r\n \t\u003cli\u003e06 Identifying Patients at Risk for Cardiac Toxicity from Chemotherapy – Update on How to Monitor and Preventive Strategies\u003c\/li\u003e\r\n \t\u003cli\u003e07 Reducing Cardiovascular Risk in Our Patients- Case Presentation and Panel Discussion\u003c\/li\u003e\r\n \t\u003cli\u003e08 Recognizing and Treating Patients with Amyloidosis\u003c\/li\u003e\r\n \t\u003cli\u003e09 Cardiac Myosin Inhibitors and Other New Treatment Options for Patients with Hypertrophic Cardiomyopathy\u003c\/li\u003e\r\n \t\u003cli\u003e10 Identifying and Treating Sarcoidosis and Other Infiltrative Diseases That Cause Heart Failure\u003c\/li\u003e\r\n \t\u003cli\u003e11 Gene Therapy for Monogenic Causes of Heart Failure and Other Cardiovascular Disease\u003c\/li\u003e\r\n \t\u003cli\u003e12 Pulmonary Arterial Hypertension (PAH)\u003c\/li\u003e\r\n \t\u003cli\u003e13 Heart Failure Management in Adult Congenital Heart Disease\u003c\/li\u003e\r\n \t\u003cli\u003e14 Peripartum Cardiomyopathy\u003c\/li\u003e\r\n \t\u003cli\u003e15 Case Presentation and Panel Discussion\u003c\/li\u003e\r\n \t\u003cli\u003e16 Coffee and Master Class on Physical Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003e17 Monitoring Devices To Identify and Treat Congestion\u003c\/li\u003e\r\n \t\u003cli\u003e18 Treating Patients with HFrEF-The Four Pillars of Therapy\u003c\/li\u003e\r\n \t\u003cli\u003e19 Adjunctive Medical Therapy for Treating Patients with HFrEF\u003c\/li\u003e\r\n \t\u003cli\u003e20 Treating Patients with HFpEF – How Do the Experts Do It\u003c\/li\u003e\r\n \t\u003cli\u003e21 Using Biomarkers To Identify and Manage Heart Failure\u003c\/li\u003e\r\n \t\u003cli\u003e22 Novel Approaches for Recognizing and Treating Congestion\u003c\/li\u003e\r\n \t\u003cli\u003e23 How to Talk So Patients with Listen How to Listen So Patients Will Talk\u003c\/li\u003e\r\n \t\u003cli\u003e24 Case Presentation\u003c\/li\u003e\r\n \t\u003cli\u003e25 Identifying and Treating Cardiogenic Shock\u003c\/li\u003e\r\n \t\u003cli\u003e26 Percutaneous Devices for Temporary Support of Cardiac Function\u003c\/li\u003e\r\n \t\u003cli\u003e27 Catheter Based Treatments of Valvular Heart Disease\u003c\/li\u003e\r\n \t\u003cli\u003e28 Left Atrial Occlusion Devices for Preventing Thromboemboli Complications of Atrial Fibrillation\u003c\/li\u003e\r\n \t\u003cli\u003e29 Advances in Preventing Sudden Cardiac Death in Patients with Heart Failure\u003c\/li\u003e\r\n \t\u003cli\u003e30 Stage D Heart Failure and Available Treatment Options to Improve Outcomes\u003c\/li\u003e\r\n \t\u003cli\u003e30 Stage D Heart Failure and Available Treatment Options to Improve Outcomes\u003c\/li\u003e\r\n \t\u003cli\u003e31 Palliative and Hospice Care for Patients with Advanced Heart Failure\u003c\/li\u003e\r\n \t\u003cli\u003eSDHF Winter Symposium 2025.pdf\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954522558562,"sku":"MED-AMB05251","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Complete-Conference-Management-San-Diego-Heart-Failure-Symposium-for-Primary-Care-and-Internal-Medicine-Physicians-2025_f67af835-f9a6-40e7-a56b-a678042898ac.jpg?v=1779378824","url":"https:\/\/meducourse.com\/products\/complete-conference-management-san-diego-heart-failure-symposium-for-primary-care-and-internal-medicine-physicians-2025","provider":"Meducourse","version":"1.0","type":"link"}